Measuring Innovation in the 21st Century Economy

Hadzimustafa, Shenaj; Rexhepi, Gadaf

doi:10.2139/ssrn.1929039

Cited by 3 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mulgan et al describe the different degrees of innovation as incremental, radical, and transformative. In their papers [5,7], they explore ways in which the concept of innovation varies across different individuals and organizations, thus accounting for the lack of a unified definition of innovation [8][9][10][11][12]. One such definition covering innovative aspects with respect to the product, process, or structure states that "health care innovation can be defined as the introduction of a new concept, idea, service, process, or product aimed at improving treatment, diagnosis, education, outreach, prevention and research, and with the long-term goals of improving quality, safety, outcomes, efficiency, and costs" [6].…”

Section: Introductionmentioning

confidence: 99%

Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review

et al. 2023

View full text Add to dashboard Cite

Background The concept of health care innovation varies across organizations and countries. Harmonizing the definitions of innovation can augment the discovery of new therapies, minimize costs, and streamline drug development and approval processes. A systematic literature review (SLR) was conducted to gather insights surrounding different elements of innovation in the USA, the UK, France, Germany, and Japan. The SLR identified studies that have defined innovation and captured the types of incentives provided to promote innovation. Methods The MEDLINE, Embase, and EconLit databases were searched via the OVID SP platform on October 22, 2020. A secondary desk search literature review was performed to identify additional information of interest in regional languages: French, German, and Japanese. All the relevant literature in English was screened using the Linguamatics natural language processing (NLP) tool, except for articles from EconLit, which were screened manually using structured search strategies. Articles that describe a definition of innovation or refer to a definition of innovation published were included. All full-text articles were reviewed manually, and two reviewers independently screened the full texts for eligibility. Results After screening, 90 articles were considered to meet the SLR objectives. The most common dimension of innovation identified was therapeutic benefit as a measure of innovation, followed by newness and novelty aspects of innovations. Incentives around exclusivities were found to be the most prevalent in the data set, followed by rewards and premiums. Among the different therapy areas, the largest number of innovations was targeted at oncology. Conclusions This SLR highlights the lack of a unified definition of innovation among regulatory authorities and health technology assessment bodies in five countries, and variation in the types of incentives associated with innovation. The targeted countries cover different dimensions of definition and incentives of innovation at varying levels, with a few focused on specific therapy areas. Harmonization and consensus for innovation would be needed across countries because drug development is a global undertaking. This SLR envisages a more holistic approach to evaluation, wherein the value provided to patients and health systems is accounted for. The results of this SLR will help to promote broader discussion among different stakeholders and decision makers across countries to identify gaps in policies and develop sustainable strategies to promote innovation for pharmaceutical products. Supplementary Information The online version contains supplementary material available at 10.1007/s40290-022-00457-5.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review

et al. 2023

View full text Add to dashboard Cite

show abstract

New Developments in Technology Management Education: Background Issues, Program Initiatives, and a Research Agenda.

Phan¹,

Siegel²,

Wright³

2009

Academy of Management Learning &Amp; Education

View full text Add to dashboard Cite

Financing innovations in the contemporary world

Madžar¹

2021

Revizor

View full text Add to dashboard Cite

As a practical application of new ideas, innovation is a multidimensional, complex, dynamic, long-term, and cumulative process based on organizational decision-making, from the stage of a new idea's emergence to its final implementation. There is a strong positive correlation between innovation and economic growth. Access to finance is a key driver of new innovative ventures' creation, survival, and growth. On the other hand, the lack of financial resources prevents and inhibits the growth and development of new innovative companies. This paper considers bootstrapping, crowdfunding, and mezzanine financing as widely accepted, specific innovation funding sources worldwide.

show abstract

Measuring Innovation in the 21st Century Economy

Cited by 3 publications

References 1 publication

Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review

Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review

New Developments in Technology Management Education: Background Issues, Program Initiatives, and a Research Agenda.

Financing innovations in the contemporary world

Contact Info

Product

Resources

About